Description: Valeant Pharmaceuticals just spent the year in the “make William Ackman even richer” business.
Source: NYTimes.com
Date: Nov 26, 2014
Link: http://dealbook.nytimes.com/2014/11/26/failed-allergan-deal-strains-valeants-business-model/
Questions for Discussions:
- Summarize the events described in this takeover battle.
- Who benefited the most?
- Were there any ”losers”?
Leave a Reply